By Bryan A. Liang and Tim K. Mackey
On March 31, 2010, Pfizer, the world's largest drug maker, announced that it had paid some $35 million dollars in the last six months of 2009 to health care practitioners, academic medical centers and other research groups. This included amounts given to over 4,500 physicians and other medical professionals for consulting, speaking engagements, meals and business expenses.
Pfizer's public disclosur...
To continue reading, please subscribe.
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In